The second panel features insights from Forrest Brown (VP Client Services, Germfree) and Krisha Patel (Co-Founder, Assurea), as they delve into the intricacies of decentralized manufacturing. They discuss key regulatory considerations and validation strategies for the decentralized manufacturing of gene therapies. Looking ahead, they anticipate a future where cybersecurity becomes a paramount focus, and interconnected systems enable better process characterization and real-time release of products. Watch the full session, below.